Clinical profile of cutaneous drug reactions
Keywords:
Clinical profile, adverse drug reactionsAbstract
Objective To find out the clinical profile of cutaneous drug reactions in a tertiary level hospital. Methods In this cross-sectional study, carried out for a period from January 2011 to December 2011, data were collected from the Department of Dermatology and Venereology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh. Patients suffering from adverse drug reactions were the study population and within the period of data collection, twenty patients were selected. Results Out of total twenty patients, 9 (45%) had fixed drug eruptions, 4 (20%) urticaria, 3 (15%) Stevens-Johnson syndrome, 2 (10%) morbilliform rashes and 2 (10%) had erythema multiforme. The most common clinical presentation was hyperpigmented macule/patch in 5 (25%) cases, followed by urticarial plaque 4 (20%), erosive lesion 3 (15%) and loss of skin in sheets <10% body surface area 3 (15%) and morbilliform rashes and target lesions in 2(10%) each. 6 (30%) patients developed mucosal involvement only and majority of them 8 (40%) had oral involvement. The most common type of offending drug causing the drug reactions were sulfur containing drugs in 8 (40%) cases, followed by NSAIDs in 6 (30%), quinolones 3 (15%), metronidazole and anticonvulsants in a few. Conclusion The common types of cutaneous drug eruptions are fixed drug eruptions, urticaria, Stevens-Johnson syndrome, morbilliform rashes and erythema multiforme. ÂReferences
Marc A, Riedl MD, Adrian M, Casillas MD. Adverse drug reactions: types and treatment options. Am Fam Physician. 2003;68:1781-91.
James WD, Berger TG, Elston D. Andrew’s Disease of the Skin-Clinical Dermatology. 10th edition. Philadelphia: Saunders Elsevier; 2006.
Shear NH, Knowles SR, Shapiro L. Cutaneous reactions to drugs. In: Wolff K, Goldsmith LA Katz SI et al., editors. Fitzpatrick’s Dermatology in General Medicine. 8th edition. New York: McGraw- Hill Companies; 2003. P.355-61.
Ahmad FU, Mahapatra AK. Phenytoin-induced toxic epidermal necrolysis in a neurosurgical patient. Neurol India. 2007;55:181-2.
Jhaj R, Uppal R, Malhotra S, Bhargava VK. Cutaneous adverse reactions in-patients in a tertiary care hospital. Indian J Dermatol Venereol Leprol. 1999;65:14-7.
Shrivastava D, Kumar A, Singh SK. Adverse drug reaction monitoring in patients attending skin O.P.D at a teaching hospital. Indian J Pharmacol. 2004;36:S42.
Devi K, George S, Criton S et al. Carbamazepine - the commonest cause of toxic epidermal necrolysis and Steven Johnson syndrome: A study of 7 years. Indian J Dermatol Venereol Leprol. 2005;71:325-8.
Sehgal S, Balachandran C, Shenoi SD. Clinical study of cutaneous drug reaction in 80 patients. Indian J Dermatol Venereol Leprol. 2003;69:6-7.
Patel RM, Marfatia YS. Clinical study of cutaneous drug reaction in 200 patients. Indian J Dermatol Venereol Leprol. 2008;74:430.
Sharma VK, Sethuraman G, Kumar B. Cutaneous adverse drug reactions: Clinical pattern and causative agents- a 6 year series from Chandigarh, India. J Postgrad Med. 2001;47:95-9.
Ghosh S, Acharya LD, Rao PGM. Study and evaluation of the various cutaneous adverse drug reactions in Kasturba hospital, Manipal. Indian J Pharm Sci. 2006;68:212-5.
